Glucagon-Like Peptide-1 Is Prognostic of Mortality in Acute Respiratory Failure

OBJECTIVES:. The incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) have therapeutic effects in diabetes mellitus. Prior clinical studies suggest incretins are prognostic of adverse outcomes in critical illness. We investigated whether incretin level...

Full description

Saved in:
Bibliographic Details
Main Authors: Cole E. Hansell, MD, Hamam A. Aneis, MD, Georgios D. Kitsios, MD, PhD, William G. Bain, MD, Yanwu Zhao, BS, Tomeka L. Suber, MD, PhD, John W. Evankovich, MD, Lokesh Sharma, PhD, Sadeesh K. Ramakrishnan, PhD, Niall T. Prendergast, MD, Matthew K. Hensley, MD, MPH, Shehryar Malik, MD, Nancy Petro, BS, Jayshil J. Patel, MD, Seyed Mehdi Nouraie, MD, PhD, Charles S. Dela Cruz, MD, PhD, Yingze Zhang, PhD, Bryan J. McVerry, MD, Faraaz A. Shah, MD, MPH
Format: Article
Language:English
Published: Wolters Kluwer 2025-04-01
Series:Critical Care Explorations
Online Access:http://journals.lww.com/10.1097/CCE.0000000000001247
Tags: Add Tag
No Tags, Be the first to tag this record!